A1LN34 (Brazil) Performance
| A1LN34 Stock | BRL 73.50 0.84 1.16% |
The firm shows a Beta (market volatility) of 0.19, which signifies not very significant fluctuations relative to the market. As returns on the market increase, A1LN34's returns are expected to increase less than the market. However, during the bear market, the loss of holding A1LN34 is expected to be smaller as well. A1LN34 today shows a risk of 2.75%. Please confirm A1LN34 coefficient of variation, jensen alpha, sortino ratio, as well as the relationship between the information ratio and total risk alpha , to decide if A1LN34 will be following its price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days A1LN34 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong essential indicators, A1LN34 is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
| Quick Ratio | 4.59 | |
| Fifty Two Week Low | 31.57 | |
| Fifty Two Week High | 53.70 |
A1LN34 |
A1LN34 Relative Risk vs. Return Landscape
If you would invest 7,399 in A1LN34 on September 24, 2024 and sell it today you would lose (49.00) from holding A1LN34 or give up 0.66% of portfolio value over 90 days. A1LN34 is generating 0.0279% of daily returns and assumes 2.7538% volatility on return distribution over the 90 days horizon. Simply put, 24% of stocks are less volatile than A1LN34, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
A1LN34 Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for A1LN34's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as A1LN34, and traders can use it to determine the average amount a A1LN34's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0101
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | A1LN34 |
Estimated Market Risk
| 2.75 actual daily | 24 76% of assets are more volatile |
Expected Return
| 0.03 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average A1LN34 is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of A1LN34 by adding A1LN34 to a well-diversified portfolio.
A1LN34 Fundamentals Growth
A1LN34 Stock prices reflect investors' perceptions of the future prospects and financial health of A1LN34, and A1LN34 fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on A1LN34 Stock performance.
| Return On Equity | -78.71 | |||
| Return On Asset | -13.65 | |||
| Profit Margin | (128.96) % | |||
| Operating Margin | (109.35) % | |||
| Current Valuation | 5.15 B | |||
| Shares Outstanding | 2.35 B | |||
| Price To Book | 6.22 X | |||
| Price To Sales | 170.35 X | |||
| Revenue | 687.53 M | |||
| EBITDA | (708.47 M) | |||
| Cash And Equivalents | 1.9 B | |||
| Cash Per Share | 15.99 X | |||
| Total Debt | 761.07 M | |||
| Debt To Equity | 0.89 % | |||
| Book Value Per Share | 7.89 X | |||
| Cash Flow From Operations | (590.99 M) | |||
| Earnings Per Share | (37.45) X | |||
About A1LN34 Performance
By analyzing A1LN34's fundamental ratios, stakeholders can gain valuable insights into A1LN34's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if A1LN34 has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if A1LN34 has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing RNA interference therapeutics. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. ALNYLAM PHARDRN operates under Biotechnology classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 1453 people.Things to note about A1LN34 performance evaluation
Checking the ongoing alerts about A1LN34 for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for A1LN34 help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| The company reported the revenue of 687.53 M. Net Loss for the year was (886.68 M) with profit before overhead, payroll, taxes, and interest of 414.8 M. | |
| A1LN34 has accumulated about 1.9 B in cash with (590.99 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 15.99. |
- Analyzing A1LN34's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether A1LN34's stock is overvalued or undervalued compared to its peers.
- Examining A1LN34's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating A1LN34's management team can have a significant impact on its success or failure. Reviewing the track record and experience of A1LN34's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of A1LN34's stock. These opinions can provide insight into A1LN34's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for A1LN34 Stock analysis
When running A1LN34's price analysis, check to measure A1LN34's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy A1LN34 is operating at the current time. Most of A1LN34's value examination focuses on studying past and present price action to predict the probability of A1LN34's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move A1LN34's price. Additionally, you may evaluate how the addition of A1LN34 to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |